1. Home
  2. PNR vs PEN Comparison

PNR vs PEN Comparison

Compare PNR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PNR

Pentair plc.

N/A

Current Price

$67.44

Market Cap

11.1B

Sector

Industrials

ML Signal

N/A

Logo Penumbra Inc.

PEN

Penumbra Inc.

N/A

Current Price

$319.84

Market Cap

12.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PNR
PEN
Founded
1966
2004
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
12.7B
IPO Year
2003
2015

Fundamental Metrics

Financial Performance
Metric
PNR
PEN
Price
$67.44
$319.84
Analyst Decision
Buy
Hold
Analyst Count
17
17
Target Price
$73.73
★ $362.54
AVG Volume (30 Days)
★ 2.9M
372.8K
Earning Date
10-27-2026
10-29-2026
Dividend Yield
★ 1.61%
N/A
EPS Growth
5.88
★ 1155.56
EPS
2.76
★ 2.77
Revenue
N/A
★ $1,403,665,000.00
Revenue This Year
N/A
$14.38
Revenue Next Year
$18.38
$12.84
P/E Ratio
★ $24.24
$115.23
Revenue Growth
N/A
★ 17.50
52 Week Low
$51.13
$277.54
52 Week High
$109.09
$362.41

Technical Indicators

Market Signals
Indicator
PNR
PEN
Relative Strength Index (RSI) 60.22 46.99
Support Level $57.60 $315.83
Resistance Level $71.92 $320.08
Average True Range (ATR) 1.96 2.45
MACD -0.40 -0.26
Stochastic Oscillator 26.77 23.52

Price Performance

Historical Comparison
PNR
PEN

About PNR Pentair plc.

Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.2 billion in revenue in 2025.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: